BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:SAE Media Group Introduces the 4th Annual…Injectable Drug Deli
 very Conference 202211th May to 12th May 2022\,London\, United Kingdomwww
 .injectable-drug-delivery.com/\n\nInnovations in Formulation and Device D
 esign for Enhanced Subcutaneous Delivery\n\nAs Part of Europe’s leading I
 njectable conference series\, we will assess innovations in drug product 
 formulation and biologics\, new technologies in device design and the use
  of long-release injectable compounds.\n\nThere is a rising demand for va
 ccines\, insulin\, and many modern medicines used to treat cancer and oth
 er chronic diseases. As biologics are mainly administered through the inj
 ectable route\, the significant growth in the biologics market is expecte
 d to drive the injectable drug delivery and prefilled syringe market in t
 he coming years. The injectable drug delivery market is expected to rise 
 at a compound annual growth rate of 12.9% reaching £915 billion by 2027.T
 his year’s event will highlight the significance of sustainability within
  the injectable drug delivery industry\, whilst also providing regulatory
  insight on the changes that have occurred. There will be an additional f
 ocus on the impact that covid has had on the success within this industry
  over the past year. The conference will also highlight successes within 
 the industry and the formulation challenges of long-lasting\, highly visc
 ous and high-volume drug delivery.\n\nThe benefits of attending:• Discove
 r the new technologies and latest injectable devices being used within th
 e industry• Develop your understanding of high-volume and long-acting inj
 ectable compounds• Explore the sustainable possibilities that can be adap
 ted within the industry for a green future• Delve into the world of biolo
 gics and biosimilars and what these mean for the injectable drug market• 
 Network with key industry leaders and discover the leading companies with
 in the injectables space\n\nWho should attend:Executives\, Directors\, VP
 s\, Heads\, Principals\, Managers\, Scientists\, Researchers of:• Autoinj
 ectors• Wearables• Device Engineering• Human Factors• CMC• Injectables• S
 terile Manufacturing• Packaging• Regulatory Affairs\n\nFeatured Speakers:
 • Alexander Zuern\, Device testing manager\, Novartis International AG• A
 ndrew Warrington\, Project Leader &amp\; Patient Advocate\, Novartis• Ben
 jamin Werner\, Scientist\, Boehringer Ingelheim Pharma GmbH &amp\; Co. KG
 • Bjorg K Hunter\, Regulatory Manager\, Devices\, GSK• Blake Green\, Seni
 or Manager Regulatory Affairs\, Amgen• Camille Dagallier\, Formulation an
 d Drug Process Development Senior Scientist\, Sanofi• Christopher Muenzer
 \, Senior Device Technology Manager\, Novartis• Joel Richard\, Head of Te
 chnical &amp\; Pharmaceutical Operations\, MedinCell• Mark Palmer\, Scien
 tific Leader\, Biopharm Device Engineering\, GSK• Rebecca Moses\, Directo
 r\, Core Human Factors Inc.• Rupal Nguyen\, Principal Engineer\, Allergan
 • Stefania Ragone\, Pharmaceutical Assessor\, Medicines &amp\; Healthcare
  Products Regulatory Agency (MHRA)• Tina Arien\, Principal Scientist\, Ja
 nssen Pharmaceutica• Vikas Jaitely\, Director\, Global Regulatory Affairs
  Transitional Medicine and Devices\, Merck\n\nPast attendees have include
 dAdvanz Pharma\; Amgen\; AstraZeneca\; BD - Becton Dickinson\; Bd Medical
 -Pharmaceutical Systems\; BD Technologies and Innovation\; Becton Dickins
 on\; Boehringer Ingelheim GmbH &amp\; Co. KG\; Boehringer Ingelheim Pharm
 a GmbH &amp\; Co. KG\; BSI Group\; Chugai Pharmaceutical CO. LTD.\; Conge
 nius\; Core Human Factors\; F Hoffmann -La Roche Inc\; GlaxoSmithKline\; 
 Glenmark Pharmaceuticals Inc.\; GSK\; Haselmeierá\; Haughton Design Ltd\;
  Ipsen Biopharm Limited\; Janssen Pharmaceutica\; Janssen Pharmaceutica N
 V\; Legacy Allergan/AbbVie\; LEO Pharma A/S\; MedinCell\; Merck\; Merck C
 onnected Health &amp\; Devices\; MHRA\; Micropore Technologies Ltd\; Nova
 rtis / DD&amp\;C\; Novartis International AG\; Novo Nordisk Pharma\; Owen
  Mumford\; Pfizer UK Limited\; Raumedic AG\; Roche\; SABIC\; Sabic SHPP\;
  Sandoz – A Novartis Company\; Sanofi\; Sanofi SWI\; Team Consulting\; Te
 va Pharamceuticals\; UCB\; Vetter Pharma-Fertigung GmbH &amp\; Co. KG\; Z
 ealand Pharma A/S\n\nAdditional Contact Info:T: +44 (0)20 7827 6088E: rjo
 nes@smi-online.co.ukLinkedIn: @SMi PharmaTwitter: @SMiPharm #SMiInjectabl
 es\n
DTEND:20220512T180000
DTSTAMP:20260512T220030Z
DTSTART:20220511T080000
LOCATION:Holiday Inn London - Kensington Forum\, an IHG Hotel\, 97 Cromwel
 l Road\, Greater London\, England\, SW7 4DN\,
SEQUENCE:0
SUMMARY:SAE Media Group Introduces the 4th Annual…Injectable Drug Delivery
  Conference 202211th May to 12th May 2022\,London\, United Kingdomwww.inj
 ectable-dr...
UID:69ec0bd4-ef5d-4422-a8a7-fc41f9ca1977
END:VEVENT
END:VCALENDAR